glp 1 liver disease GLP-1 Receptor Agonists in Non-Alcoholic Fatty Disease: Current Evidence and Future Perspectives What Is Fatty Liver Disease?

After the introduction of negatively charged crotonyl group, the positive charge of histone decreases, and binds to negatively charged DNA more loosely, which is conducive to the binding of transcription factors 137

The phase III randomized trial MIND-DC 31 (NCT02993315), evaluating natural DC vaccines versus placebo for stage III cancers, was used for biomarker validation based on serum metabolomics data

Furthermore, migraine poses a risk factor for headache development, and migraine-like headache being associated with lower likelihood of headache improvement and headache freedom after one year [31]

2026;6:1004136 DOI: Received: August 17, 2025 Accepted: November 24, 2025 Published: January 04, 2026 Academic Editor: Shile Huang, Louisiana State University Health Science Center, USA Neurodegenerative diseases, including Alzheimers, Parkinsons, Huntingtons, and Amyotrophic Lateral Sclerosis, are characterized by multifactorial pathologies that extend beyond neuronal loss to include neuroinflammation, oxidative stress, mitochondrial dysfunction, and glial dysregulation

Explore Empire's hands-on, CME-accredited Medical Weight Loss & Metabolic Health courses live patients, expert faculty, and ongoing mentorship